France · Delayed Price · Currency is EUR BIO-UV Group Statistics
Total Valuation
BIO-UV Group has a market cap or net worth of EUR 19.16 million. The enterprise value is 29.21 million.
| Market Cap | 19.16M |
| Enterprise Value | 29.21M |
Important Dates
The next estimated earnings date is Thursday, June 18, 2026.
| Earnings Date | Jun 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BIO-UV Group has 13.59 million shares outstanding. The number of shares has increased by 33.08% in one year.
| Current Share Class | 13.59M |
| Shares Outstanding | 13.59M |
| Shares Change (YoY) | +33.08% |
| Shares Change (QoQ) | +3.72% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.10% |
| Float | 13.43M |
Valuation Ratios
The trailing PE ratio is 23.45.
| PE Ratio | 23.45 |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| PB Ratio | 0.47 |
| P/TBV Ratio | 2.34 |
| P/FCF Ratio | 6.40 |
| P/OCF Ratio | 4.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.23, with an EV/FCF ratio of 9.76.
| EV / Earnings | 34.93 |
| EV / Sales | 0.79 |
| EV / EBITDA | 13.23 |
| EV / EBIT | 18.82 |
| EV / FCF | 9.76 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.50.
| Current Ratio | 2.15 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 9.16 |
| Debt / FCF | 6.76 |
| Interest Coverage | 2.04 |
Financial Efficiency
Return on equity (ROE) is 2.28% and return on invested capital (ROIC) is 2.85%.
| Return on Equity (ROE) | 2.28% |
| Return on Assets (ROA) | 1.43% |
| Return on Invested Capital (ROIC) | 2.85% |
| Return on Capital Employed (ROCE) | 2.76% |
| Weighted Average Cost of Capital (WACC) | 4.57% |
| Revenue Per Employee | 250,843 |
| Profits Per Employee | 5,689 |
| Employee Count | 147 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.20 |
Taxes
In the past 12 months, BIO-UV Group has paid 65,365 in taxes.
| Income Tax | 65,365 |
| Effective Tax Rate | 7.25% |
Stock Price Statistics
The stock price has decreased by -32.29% in the last 52 weeks. The beta is 0.27, so BIO-UV Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -32.29% |
| 50-Day Moving Average | 1.35 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 54.64 |
| Average Volume (20 Days) | 25,792 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIO-UV Group had revenue of EUR 36.87 million and earned 836,336 in profits. Earnings per share was 0.06.
| Revenue | 36.87M |
| Gross Profit | 23.93M |
| Operating Income | 1.55M |
| Pretax Income | 901,701 |
| Net Income | 836,336 |
| EBITDA | 2.21M |
| EBIT | 1.55M |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 10.18 million in cash and 20.23 million in debt, with a net cash position of -10.05 million or -0.74 per share.
| Cash & Cash Equivalents | 10.18M |
| Total Debt | 20.23M |
| Net Cash | -10.05M |
| Net Cash Per Share | -0.74 |
| Equity (Book Value) | 40.53M |
| Book Value Per Share | 2.98 |
| Working Capital | 14.79M |
Cash Flow
In the last 12 months, operating cash flow was 4.63 million and capital expenditures -1.64 million, giving a free cash flow of 2.99 million.
| Operating Cash Flow | 4.63M |
| Capital Expenditures | -1.64M |
| Depreciation & Amortization | 656,318 |
| Net Borrowing | -3.76M |
| Free Cash Flow | 2.99M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 64.91%, with operating and profit margins of 4.21% and 2.27%.
| Gross Margin | 64.91% |
| Operating Margin | 4.21% |
| Pretax Margin | 2.45% |
| Profit Margin | 2.27% |
| EBITDA Margin | 5.99% |
| EBIT Margin | 4.21% |
| FCF Margin | 8.11% |
Dividends & Yields
BIO-UV Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.08% |
| Shareholder Yield | -33.08% |
| Earnings Yield | 4.37% |
| FCF Yield | 15.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIO-UV Group has an Altman Z-Score of 1.39 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.39 |
| Piotroski F-Score | 8 |